Through a longitudinal analysis within a cohort from the Shanghai Aging Study (n = 118), Shen et al.22 showed that cognitively normal individuals who later developed Alzheimer’s disease presented higher baseline GFAP compared with those who did not convert to Alzheimer’s disease. This evidence concerns the gene GFAP and Alzheimer disease.